Boobalan Pachaiyappan

Raghuram Selvaraju

Michael Okunewitch

- Longeveron Inc. (LGVN) entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC on **September 19, 2025**, to sell up to **$10,700,000** of its Class A common stock.  **[1721484_0001213900-25-089595_ea025785501ex1-1_long.htm:0]** **[1721484_0001213900-25-089595_ea025785501ex5-1_long.htm:1]** **[1721484_0001213900-25-089595_ea0257855-8k_long.htm:1]** 
- H.C. Wainwright & Co., LLC will serve as the sales agent, earning a **3.0%** commission on the gross sales price of the shares sold.  **[1721484_0001213900-25-089595_ea0257855-8k_long.htm:2]** 
- The net proceeds from the offering are designated for the **clinical and regulatory development of laromestrocel**, regulatory approvals, capital expenditures, working capital, and general corporate purposes.  **[1721484_0001213900-25-089595_ea0257855-8k_long.htm:2]**

Longeveron (LGVN)